Analysis of Impurities in Pharmaceuticals Using LCMS-9030Quadrupole Time-of-Flight Liquid Chromatograph-Mass Spectrometer

Significance of the Topic

Identifying trace impurities in pharmaceuticals is critical for product safety and regulatory compliance. Traditional HPLC-UV methods provide quantitative impurity profiles but lack structural information. Combining UHPLC with high-resolution quadrupole time-of-flight mass spectrometry enables precise determination of impurity composition, structure elucidation, and database-assisted identification, thus strengthening quality assurance workflows.

Objectives and Study Overview

This application note demonstrates the use of the Shimadzu LCMS-9030 QTOF coupled with Nexera X3 UHPLC and LabSolutions Insight Explore software for comprehensive impurity analysis in montelukast sodium. The study aims to:

• Detect impurity peaks by UV and MS
• Estimate elemental composition and assign fragment structures
• Confirm identity against recognized pharmacopoeial impurities

Methodology and Instrumentation

The test sample (Solution A, 1 mg/mL montelukast sodium) was prepared per the Japanese Pharmacopoeia. UHPLC separation used a Shim-pack Scepter Phenyl-120 column (50×2.1 mm, 1.9 µm) with a gradient of water/formic acid and acetonitrile/formic acid at 0.25 mL/min, 30 °C, UV detection at 238 nm. MS analysis employed the LCMS-9030 in positive ESI mode (MS/MS scans) with gas flows (nebulizing 3.0 L/min, drying 10.0 L/min, heating 10.0 L/min) and interface temperatures (DL 250 °C, heat block 400 °C, interface 300 °C).

Results and Discussion

Five impurity peaks (retention 4.55–15.13 min) were detected alongside the principal montelukast peak (~9.97 min). Extracted ion chromatograms revealed m/z values 602.2126, 732.2579, 570.1864, 568.2072. Composition estimation identified C34H32NO3SCl for impurity E (m/z 570.1864). Fragment assignment via Insight Explore matched theoretical ions to observed MS/MS spectra. Database search (ChemSpider) confirmed known JP impurities A–F. Mass accuracy was within 1 mDa for all targets.

Benefits and Practical Applications

• High mass accuracy enables reliable structural elucidation of trace impurities
• Automated composition estimation and fragment assignment streamline workflows
• Database integration supports rapid confirmation of pharmacopoeia-listed impurities
• Suitable for QA/QC in pharmaceutical manufacturing and regulatory submissions

Future Trends and Applications

Anticipated developments include integration of AI-driven spectral interpretation, expansion of structural databases, enhanced sensitivity for ultra-trace detection, and real-time process monitoring in pharmaceutical and other industries such as food safety and environmental testing.

Conclusion

The Shimadzu LCMS-9030 QTOF system combined with LabSolutions Insight Explore provides a robust platform for comprehensive impurity profiling, delivering accurate structural identification and supporting rigorous quality control in pharmaceutical analysis.

Used Instrumentation

• Shimadzu Nexera X3 UHPLC system
• Shim-pack Scepter Phenyl-120 column
• Shimadzu LCMS-9030 quadrupole time-of-flight mass spectrometer
• LabSolutions Insight Explore software